Cargando…
Cerebrospinal fluid analysis in 108 patients with progressive multifocal leukoencephalopathy
BACKGROUND: Progressive multifocal leukoencephalopathy (PML) is caused by an opportunistic infection with JC polyoma virus (JCPyV) and mainly affects immunocompromised patients. It leads to pronounced demyelination of the central nervous system (CNS) resulting in severe disability or even death. Det...
Autores principales: | Möhn, Nora, Luo, Yi, Skripuletz, Thomas, Schwenkenbecher, Philipp, Ladwig, Anne, Warnke, Clemens, Meuth, Sven G., Wiendl, Heinz, Gross, Catharina C., Schröder, Christoph, Haghikia, Aiden, Stangel, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590675/ https://www.ncbi.nlm.nih.gov/pubmed/33109245 http://dx.doi.org/10.1186/s12987-020-00227-y |
Ejemplares similares
-
Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2019) -
Targeted metabolomic profiling of cerebrospinal fluid from patients with progressive multifocal leukoencephalopathy
por: Luo, Yi, et al.
Publicado: (2020) -
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2022) -
Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF
por: Möhn, Nora, et al.
Publicado: (2019) -
PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy
por: Möhn, Nora, et al.
Publicado: (2021)